Introduction
Nitric oxide (NO) is a gas, which is continuously synthesized in endothelial cells and executes multiple functions that maintain vascular homeostasis. In the vascular system NO is synthesized by the type III isoform of NO synthases (endothelial NOS). 1, 2 When NO is released from the endothelium, it may diffuse abluminally into smooth muscle cells causing vasodilation; when released luminally into the blood stream NO reacts with intraerythrocytic oxyhemoglobin to form nitrate, while a portion of the remaining NO is oxidized to nitrite. 3, 4 We have recently shown that nitrite has the potential to be a major intravascular NO storage molecule in humans that is capable of transducing NO bioactivity distal to its site of formation. 5 Plasma nitrite has been described as an index of endothelial NOS activity in the regional 6 and systemic circulation in humans and various mammals. 7 Despite the growing appreciation of an important potential role for nitrite in physiology and as a disease marker, the actual circulating levels of nitrite in humans have been difficult to measure, owing to the relative instability of nitrite in blood, as well as due to contaminating nitrite in clinical blood collection tubes and labware. This has resulted in reported levels ranging from undetectable 8 to 20 µmol/L. 9 A recent report identified some of the analytical problems of measuring nitrite in plasma, potentially explaining the wide range of reported levels. 7 In that study plasma nitrite was determined with three independent analytical methods and rapid sample preparations in seven mammalian species, strongly suggesting that in vivo plasma nitrite concentrations are below 500 nmol/L in mammals. The short half-life of nitrite in whole blood, demanding rapid separation of plasma from erythrocytes, is a considerable obstacle for plasma nitrite determination in clinical practice, and perhaps more importantly, the measure of plasma nitrite ignores the potential importance of erythrocytes in nitrite/ nitric oxide metabolism.
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For personal use at PENN STATE UNIVERSITY on . bloodjournal.hematologylibrary.org From Nitrite, like NO, reacts with erythrocytic oxyhemoglobin to form nitrate and methemoglobin. 10 However, nitrite will react with deoxyhemoglobin to form NO and methemoglobin 11 , a reaction that we have proposed contributes to erythrocytedependent hypoxic vasodilation. 5, 12 Such a model of dynamic intravascular blood flow regulation suggests a rapid reaction of nitrite with intra-erythrocytic hemoglobin. 5, 13 We, therefore, hypothesized that the erythrocyte might be an additional reservoir for nitrite.
In order to determine whole blood and erythrocytic nitrite concentration, we developed a ferricyanide-based hemoglobin oxidation "stabilization-solution", designed to limit ex-vivo nitrite oxidation by oxyhemoglobin and reduction by deoxyhemoglobin, that otherwise occurs after blood collection. Using this methodology, we studied the compartmentalization of nitrite in human plasma and erythrocytes and characterized mechanisms governing nitrite formation and consumption in the human circulation.
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Methods
Human subjects. Blood for human in vitro studies was drawn from normal healthy volunteers enrolled in an IRB approved human subjects blood collection protocol. To evaluate whole blood nitrite as an index of regional NO-synthase activity, eight healthy volunteers (4 women and 4 men; age range 22 -31) were enrolled in an IRB approved forearm blood flow study. Exclusion criteria were the presence of cardiovascular risk factors, liver disease, renal failure, or acute and chronic infections (including HIV). Ferricyanide-based hemoglobin oxidation assay. In order to measure nitrite in whole blood, we mixed whole blood with a nitrite preservation solution containing ferricyanide (0.8 M) (an oxidizing agent), N-ethylmaleimide (NEM; 10 mM) (a thiol alkylating agent), and NP-40 (1%) (a cytolytic agent to provide access of the ferricyanide and NEM to the red cell contents) in a 5:1 dilution (v:v; whole blood: stop solution) immediately upon blood collection. Preliminary studies showed this ratio to be optimal for consistent results (data not shown). Following blood addition to the preservation solution, the sample was deproteinated with methanol (v:v; 1:1) and spun down at 15,000 x g for 2 min. Two hundred µL of the supernatant was injected into a solution of acidified tri-iodide, purging with helium in-line with a gas-phase chemiluminescence NO analyzer (Sievers, Boulder, CO). The tri-iodide solution was prepared by mixing 2 g of potassium iodide, 1.3 g iodine dissolved in 40 mL of water with 140 mL of acetic acid. Six to eight mL of this solution was placed in the purge vessel into which samples were injected. This solution will only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From reduce nitrite, iron-nitrosyl-heme and S-nitrosothiols to NO gas, which is detected by the NO analyzer. [14] [15] [16] In additional experiments plasma and erythrocytes were immediately separated by centrifugation at 2000 x g for 1 min. Erythrocytes were treated with the ferricyanide-based preservation solution as described for whole blood above. The nitrite levels in plasma, red cells and whole blood in 15 healthy human volunteers were then determined using the reductive tri-iodide based chemiluminescence assay with and without a two-minute pre-treatment with a specific scavenger of nitrite (10% acid sulfanilamide To compare whole blood nitrite levels from humans to often used laboratory animals, we studied the whole blood nitrite levels of 25 C57BL/6 mice under basal conditions and 20 mice treated with L-NAME (100 mg/kg) intraperitoneally. Whole blood was drawn out of the retro-orbital vein from these mice. We measured whole blood nitrite 2, 4, 6, and 24 h after intraperitoneal injection of L-NAME in 5 mice at each time point.
Whole blood nitrite as an index of acute changes of NO-synthase activity in humans.
Arterial and venous angio-catheters were placed in the brachial arteries and antecubital veins of eight normal volunteers. Basal forearm blood flow was measured by venous occlusion strain-gauge plethysmography, as previously described. 19 Arterial and venous blood was drawn for the measurement of basal whole blood and erythrocyte nitrite levels. Blood for whole blood nitrite determinations was immediately treated at the bedside with nitrite preservation solution. Erythrocytes were separated after venisection by spinning whole blood at 2000 g for 1 min and were then frozen in dry ice. After basal measurements, acetylcholine (ACh) was infused at 7.5 µg/min for 3 min and every 30 s during ACh infusion venous blood was drawn and immediately mixed with nitrite preservation solution for whole blood nitrite measurements. Whole blood samples were kept on ice until measured via tri-iodide/ chemiluminescence on the same day. In additional experiments a blood pressure cuff was placed around the arm and inflated to 250 mmHg, circulatory stasis was maintained for 5 min and then the blood pressure cuff was released. The release of the blood pressure cuff triggers a flow mediated vasodilation of the brachial artery, which is nearly exclusively dependent on endothelial NO-synthase. 20 Before and 1 min after ischemia forearm blood flow was measured via venous occlusion plethysmography and venous blood was drawn for nitrite measurements. The measured coefficient of variation was 5%. There was no detectable difference between samples that were measured directly and those subjected to freeze/thaw and deproteinated with methanol (98 ± 6%, n=20) ( For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From calculated for whole blood (based on measurements in plasma and red cell fractions and corrected for hematocrit) of 15 normal volunteers were 121 ± 9, 288 ± 47, 176 ± 17, and 184 ± 22 nmol/L, respectively. Whole blood nitrite levels were similar at 8 am and 12 am in studied individuals (8 am: 181 ± 29 nmol/L and 12 am: 176 ± 17 nmol/L; n=8). Whole blood nitrite levels were similar when drawn on 3 consecutive days with a coefficient of variation of less than 5 % between measurements (n=3). The agreement between measured and calculated whole blood nitrite levels indicates the internal consistency between these methods, an important prerequisite in developing a clinically useful assay. The half-life of nitrite at room temperature in the erythrocyte pellet was similar to that in whole blood, whereas nitrite levels in plasma and water did not change measurably over 30 min (data not shown).
To investigate where nitrite was located in the erythrocyte, the cytosol was separated from the erythrocyte membrane. Virtually all nitrite was located in the cytosol, 94 ± 4% of the entire erythrocyte fraction. To test whether nitrite is bound to proteins in the cytosol of erythrocytes, we passed the cytosol through a G 25 column. This treatment of the sample eliminated the nitrite signal almost completely (Figure 2 B) .
As a comparison to humans we measured the basal and NOS inhibited whole blood nitrite levels in mice. The whole blood nitrite levels of C57BL/6 mice was 650 ± 29 nmol/L and decreased to 556 ± 26, 455 ± 11, 421 ± 18, and 551 ± 30 nmol/L at 2, 4, 6, and 24 h after intraperitoneal L-NAME injection (p=0.002).
Changes of whole blood levels in the human forearm with modulation of NOsynthase activity. To test the hypothesis that stimulation of endogenous endothelial NO synthase increases whole blood nitrite concentration, we studied human forearm blood Figure 3C ). The increase in nitrite levels in whole blood was transient during acetylcholine-stimulation of endogenous NO synthesis.
When blood was drawn from the effluent vein under acetylcholine infusion, whole blood nitrite concentration increased to a maximum ninety seconds after the infusion began and then decreased to near basal levels as the infusion continued (Figure 3 D) . Lauer et al 6 have described a similar phenomenon for plasma nitrite levels.
For
Discussion
We have established an assay for whole blood nitrite based on the use of ferricyanide to oxidize erythrocytic hemoglobin to methemoglobin and thus limit hemoglobin-dependent redox reactions with nitrite. We demonstrate that this reaction terminates hemoglobinnitrite reactions, which are responsible for the relatively rapid consumption of nitrite after blood is drawn from the body. This assay allows for room-temperature collection of blood at the bedside for the determination of actual in vivo nitrite levels in erythrocytes and whole blood. Using this assay, we find that i) the basal whole blood nitrite levels in normal resting humans are about 200 nmol/L, ii) nitrite in erythrocytes constitute about two-thirds of intravascular nitrite at concentrations approaching 300 nM, and iii) there is a whole blood and erythrocyte nitrite artery-to-vein gradient across the human forearm circulation in healthy human volunteers, consistent with a dynamic oxygen-dependent nitrite metabolism.
Whole blood nitrite increases by various stimulators of NOS activity. NO reacts
with hemoglobin in a nearly diffusion limited reaction to form nitrate and methemoglobin and with oxygen to form various oxidation products. 22 This results in an exceptionally short half-life of NO in blood and creates considerable difficulties in the direct measurement of the blood levels of the NO radical. 23 However, there is compelling evidence that one of the oxidative products of NO in blood, nitrite, reflects a constant proportion of the total endothelial NO-synthesis. This thesis is principally supported by the observation that 90% of circulating plasma nitrite is derived from NOS-activity in humans and other mammals. 24 In addition, plasma nitrite levels are reduced up to 70%
in eNOS knock-out mice as compared to control mice 7, 25 and Lauer et al 6 demonstrated that plasma nitrite levels reflect acute changes in regional NOS-activity. A valid index of NOS activity would yield insights into NO metabolism both in vitro and in vivo and may only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From also serve as a surrogate of endothelial dysfunction in patients with atherosclerosis and other diseases exhibiting a change in NO bioavailability. 26, 27 Plasma nitrite has been used as a surrogate for intravascular nitrite concentration for several reasons. First, nitrite is taken up quickly into erythrocytes from plasma and reacts with hemoglobin to form nitrate. Only a portion of intravascular nitrate is derived from NO-synthase dependent pathways; thus once nitrite is converted to nitrate it is not an index of acute changes in NO-synthase activity using currently available analytical methodologies. Second, proteins interfere with most nitrite assays 7 and by separating erythrocytes from plasma a lot of proteins are eliminated from the sample. Plasma nitrite is widely accepted as an index of NOS activity in vivo; however the need for rapid blood processing after venisection creates a considerable obstacle for plasma nitrite determination in clinical practice. Moreover, changes in intraerythrocytic nitrite cannot be evaluated.
To overcome these analytical problems, we developed a ferricyanide-based hemoglobin oxidation assay that stabilizes nitrite in lysed whole blood and the erythrocyte. The principle of the method is that ferricyanide reacts with hemoglobin to form methemoglobin (Fe-II-hemoglobin + ferricyanide -› Fe-III-hemoglobin + ferrocyanide). 28 Methemoglobin, unlike hemoglobin, does not react with nitrite to form nitrate nor does it reduce nitrite to NO. 29 Since the reaction of hemoglobin with nitrite represents the major mechanism for nitrite degradation, the addition of ferricyanide stabilizes nitrite in whole blood. We find that measurement of nitrite in whole blood using this method is sensitive, linear, and reproducible. We recently validated the reductive chemiluminescence against two other independent (Flow injection analysis combined with the Griess reagent and HPLC) assays for nitrite (r 2 =0.9). 7 Reaction of whole blood with preservation solution Erythrocytes contain the majority of intravascular nitrite in whole blood. We have recently shown that nitrite has the potential to be a major intravascular NO storage molecule and that hemoglobin acts as a nitrite reductase contributing to red blood cell dependent hypoxic vasodilation. 5, 12 Such a model requires a reaction of nitrite with intraerythrocytic hemoglobin. 5, 13 We, thus, hypothesized that erythrocytes would serve as a reservoir for intravascular nitrite. In 15 healthy individuals we could show that two-thirds of intravascular nitrite is located in erythrocytes and the majority of nitrite in erythrocytes is located in the cytosol. In these individuals we found that the levels of nitrite in the erythrocyte approached 300 nmol/L confirming a recent report by Bryan et al. 30 We found an artery-to-vein gradient for whole blood and erythrocyte nitrite in humans consistent with nitrite utilization as a source of bioactive NO in the microcirculation.
14 Upon deoxygenation of erythrocytes resident nitrite may be catalytically reduced to produce NO, putatively providing a mechanism for matching local blood flow to oxygen demand. 5 only.
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Higher concentrations of nitrite in the erythrocyte then in plasma are surprising in the presence of 20 mM heme. At first sight it may be expect that nitrite enters erythrocytes via the anion exchanger (AE-1). However, incubation of erythrocytes with DIDS, an inhibitor of AE-1, does not change the uptake rate of nitrite from plasma (data not shown), corroborating previous reports in carp, pigs, and humans. 21, 31 If nitrite would follow the Gibbs-Donnan equilibrium like bicarbonate or chloride, the ratio of erythrocyte nitrite concentration to plasma nitrite concentration would be expected to be 0.7. The apparent departure form this points either towards a more complicated mechanism of nitrite uptake from plasma 31 or a constant formation of nitrite within the erythrocyte.
These results suggest a dynamic control of nitrite decay/ nitrite reduction to NO and nitrite uptake/ formation within the erythrocyte.
There are several endothelial NOS-independent influences on blood nitrite such as the amount of nitrate in diet 32 and systemic inflammatory processes. 26 Dietary nitrate is converted to nitrite in the oral cavity by commensual bacteria containing nitrate reductase. Nitrite can then be absorbed via the gastrointestinal tract and increases time dependently plasma nitrite concentration after a nitrate challenge. To design clinical studies measuring plasma or erythrocyte nitrite one has to bear in mind the possible influence factors on intravascular nitrite concentrations.
In Figure 4 we present a summary of current knowledge about biochemical pathways of intravascular NO metabolism. As noted above, NO produced in endothelial cells by the action of eNOS, which diffuses luminally, undergoes diverse oxidative/ reductive reactions to produce the multiple valence states of NO, symbolized as N x O y . 22 These states react to a small, but potentially biologically important extent, to produce species NO, which has not yet undergone these reactions is believed to be largely destroyed by reaction with trace amounts of plasma hemoglobin 36 or to diffuse into erythrocytes to react with oxyhemoglobin to produce nitrate and methemoglobin. NO, which reacts with deoxyhemoglobin produces primarily iron-nitrosyl-hemoglobin (NO-Hb). Intraerythrocytic NO-Hb may decay under certain conditions to release NO from the erythrocyte. 37 An additional species, S-nitroso-hemoglobin (SNO-Hb) has also been postulated to be a biologic source of NO 38 , but its quantities, stability, and biological role remain uncertain.
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The present study highlights the nitrite/erythrocyte pathways that are shown on the right of Figure 4 . Nitrite ions produced in plasma from oxidation of intravascular NO can diffuse reversibly into erythrocytes and react with hemoglobin and undergo oxidative and reductive reactions. Similar to NO, intraerythrocytic nitrite, which constitutes the bulk of intravascular nitrite, reacts with oxyhemoglobin to produce methemoglobin and nitrate. 10 The reaction of nitrite with deoxyhemoglobin produces either NO or other NO intermediates which are bioactive. 5, 12, 13 (In addition it is to be noted that intravascular reduction of nitrite may occur at low pH by disporportionation and may also be catalyzed by the enzyme xanthine oxido-reductase For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From endothelin-1 45 and angiotensin II. 46 The long perceived dogma that erythrocytes merely terminate NO bioactivity limiting its action to the diffusion radius, should be modified to suggest that erythrocytes participate in the regulation of vascular homeostasis, which includes control of leukocyte adhesion, platelet aggregability, as well as vascular tone.
The development of a means to measure nitrite in whole blood and erythrocytes, 
